Loading...
Prolonged complete response following gemcitabine-erlotinib combined therapy in advanced pancreatic cancer
Pancreatic cancer is one of the most lethal types of malignant solid tumor and is typically associated with a poor prognosis. The majority of patients are diagnosed with advanced-stage disease, therefore, the median survival period is <6 months. Recently, a number of basic research projects and c...
Na minha lista:
| Udgivet i: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734067/ https://ncbi.nlm.nih.gov/pubmed/26893699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.4009 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|